Paid Clinical Trials for Low Grade Glioma of Brain

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing all 5 results

Evaluation of 18F-Fluciclovine Positron Emission Tomography – Magnetic Resonance Imaging (PET-MRI) in LGG

by CTG

in Glioma, Glioma, Malignant, Low Grade Glioma of Brain, Low-grade Glioma, Glioma Intracranial

Other

Pennsylvania

Deadline:

09/01/2027

Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib

by CTG

in Low Grade Glioma of Brain

Other

North Carolina

Deadline:

12/01/2027

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

by CTG

in Low Grade Glioma of Brain

Other

North Carolina

Deadline:

08/01/2029

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

by CTG

in Recurrent Low Grade Glioma, BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain

Other

California

Deadline:

03/31/2032

The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier

by CTG

in Low Grade Glioma of Brain

Other

California

Deadline:

01/20/2027